We analyzed PRAME mRNA expression in AML cell lines Kasumi-1, K562, NB4, THP-1, and U937, ALL cell lines Hut78, Molt-4 and Z138 before and after treatment with HDAC inhibitors chidamide or VPA in vitro. This evidence concerns the gene PRAME and acute myeloid leukemia.